Search for: "Teva Pharmaceuticals"
Results 901 - 920
of 1,429
Sorted by Relevance
|
Sort by Date
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Feb 2011, 4:29 am
The company's chief operating officer reportedly said of the suit that he has no idea what the company did wrong.The second of those cases was that of the $500 million punitive damages award against Teva Pharmaceutical Industries, upon which we reported back in May as appearing to be a case of misplaced anger. [read post]
20 May 2010, 8:31 am
But again today, May 20, 2010 the firm has upgraded the stock from Hold to Buy.According to Benzinga’s Monica Gerson who writes that Standpoint analyst Ronnie Moas had also upgraded shares of Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA), Dell Inc (NASDAQ: DELL), HP (NYSE: HPQ) and Xerox Corporation (NYSE: XRX), simultaneously, from “hold” to “buy. [read post]
21 Oct 2011, 7:40 am
Sepracor, now known as Sunovion Pharmaceuticals, requested the PTO to re-examine these patents, which now has been completed. [read post]
30 Oct 2017, 4:00 am
… Legal FeedsSCC rules banks liable for Teva employee’s fraud scheme The Supreme Court of Canada has ruled that two banks were liable for a $5.5-million cheque fraud carried out by a former employee of Teva Canada Ltd. [read post]
25 Aug 2011, 4:15 pm
• Generic companies KRKA and Teva appear in the top five applicants for patents relating to Candesartan. [read post]
6 Jun 2012, 3:52 am
For patients who need Adderall, the situation can be dire: Adderall is on the FDA’s drug shortage list, thanks to supply problems manufacturer Teva Pharmaceuticals is having with the active ingredients. [read post]
19 Apr 2010, 7:50 am
Teva denies the claims, saying its labels and packages warned against reusing vials of propofol among multiple patients, said Denise Bradley, senior director of North America Corporate Communications for Teva Pharmaceuticals. [read post]
1 Nov 2007, 4:18 pm
Patent No. 6,610,327, claiming pharmaceutical formulations of moxifloxacin. [read post]
18 Sep 2019, 6:35 am
District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a ‘fair share’ of the generic drug market and avoid price-lowering competition. [read post]
21 Jan 2010, 1:00 am
Teva Parenteral Medicines Inc. et al. [read post]
15 Jul 2021, 6:30 am
Paragard was manufactured and sold by Teva Pharmaceuticals until 2017 when The Cooper Companies, Inc. purchased Teva’s Paragard business and took over. [read post]
15 Jul 2021, 6:30 am
Paragard was manufactured and sold by Teva Pharmaceuticals until 2017 when The Cooper Companies, Inc. purchased Teva’s Paragard business and took over. [read post]
15 Jul 2021, 6:30 am
Paragard was manufactured and sold by Teva Pharmaceuticals until 2017 when The Cooper Companies, Inc. purchased Teva’s Paragard business and took over. [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
30 Jan 2020, 10:49 am
Purdue Pharma and Teva Pharmaceuticals – Oklahoma – $355 million. [read post]
6 Feb 2015, 8:57 am
Background Teva Pharmaceuticals USA, Inc. v. [read post]
18 Jan 2017, 1:28 pm
Staying with patents, as IPKat member Neil Wilkof discusses on IP Finance the challenges faced by the world’s largest generic drug company, Teva Pharmaceutical Industries Ltd (based in Israel), but whose most successful product in recent years has been the proprietary drug COPAXONE. [read post]
18 Jun 2013, 9:17 am
About 12 per cent of respondents were from Canadian companies.The survey shows corporate counsel seek to add value to the business by adopting new tactics to meet their goal, including:• Redefining strategies to obtain permits and regulatory approvals faster;• Planning for acquisitions before the business units engage in talks;• Sitting on research and development committees to spot IP opportunities earlier;• Developing settlement decision trees to get to resolution faster;… [read post]
